February 22, 2022 Corporate and Business News

• XNK Therapeutics to present at Redeye's Regenerative Medicine/Cell Therapy event on February 23

• Kin + Carta supercharges growth with latest global acquisitions

• HONEYWELL TEAMS WITH ASTRAZENECA TO DEVELOP NEXT-GENERATION RESPIRATORY INHALERS THAT USE NEAR-ZERO GLOBAL WARMING POTENTIAL PROPELLANT

• Back to Home

• Archive History